Lumos Pharma (LUMO) Institutional Ownership → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free LUMO Stock Alerts $2.25 -0.04 (-1.75%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lumos Pharma (NASDAQ:LUMO)CurrentInstitutional OwnershipPercentage33.99%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$172.63KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$1.29M Get LUMO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lumos Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LUMO Institutional Buying and Selling by Quarter Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Lumos Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Blackstone Inc.78,624$222K0.0%-75.9%0.968% 2/15/2024 Blackstone Inc.326,552$1.04M0.0%-30.2%4.128% 2/6/2024 Private Advisor Group LLC16,013$51K0.0%-20.0%0.202% 11/7/2023 Greenwich Wealth Management LLC76,341$252K0.0%+55.8%0.961% 11/3/2023 Private Advisor Group LLC20,013$66K0.0%+42.8%0.252% 10/27/2023 Marquette Asset Management LLC25,760$85K0.0%-17.1%0.324% Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 10/27/2023 Acuitas Investments LLC125,242$413K0.2%-18.6%1.577% 8/10/2023 Private Advisor Group LLC14,013$46K0.0%-30.0%0.172% 7/31/2023 Greenwich Wealth Management LLC49,002$162K0.0%+63.2%0.600% 5/1/2023 Marquette Asset Management LLC31,088$103K0.0%+47.9%0.379% 4/24/2023 Greenwich Wealth Management LLC30,028$99K0.0%N/A0.366% 2/10/2023 K2 Principal Fund L.P.15,836$57K0.0%-71.7%0.189% 1/18/2023 Private Advisor Group LLC20,013$72K0.0%+17.6%0.238% 1/12/2023 Marquette Asset Management LLC21,020$76K0.0%+57.9%0.250% 10/14/2022 Private Advisor Group LLC17,013$151K0.0%-37.0%0.203% 8/15/2022 Opaleye Management Inc.21,520$166K0.1%N/A0.257% 7/26/2022 Key Financial Inc10,916$84K0.0%N/A0.130% 7/22/2022Urban Wealth Management LLC3,490$27K0.1%N/A0.042% 2/15/2022 Lion Point Capital LP51,205$354K0.1%-87.4%0.613% 2/4/2022 Envestnet Asset Management Inc.10,368$72K0.0%N/A0.124% 2/2/2022PVG Asset Management Corp10,175$71K0.3%N/A0.122% 1/14/2022Investors Financial Group LLC30,600$212K0.1%-11.6%0.366% 11/15/2021 Minerva Advisors LLC34,015$321K0.2%N/A0.407% 11/12/2021 Renaissance Technologies LLC286,412$2.72M0.0%-6.3%3.427% 11/12/2021 Connor Clark & Lunn Investment Management Ltd.33,427$318K0.0%+4.7%0.400% 10/21/2021Investors Financial Group LLC34,600$329K0.2%+16.9%0.414% 10/12/2021 Marquette Asset Management LLC13,234$126K0.0%+48.4%0.158% 8/17/2021 Price T Rowe Associates Inc. MD159,595$1.59M0.0%N/A1.910% 8/16/2021 Opaleye Management Inc.382,000$3.82M0.6%+1.4%4.571% 8/16/2021 State Street Corp11,237$112K0.0%N/A0.134% 8/13/2021 Renaissance Technologies LLC305,757$3.06M0.0%-8.0%3.659% 8/12/2021 Dimensional Fund Advisors LP39,405$392K0.0%-5.0%0.472% 8/12/2021 Connor Clark & Lunn Investment Management Ltd.31,938$317K0.0%-4.1%0.382% 7/19/2021 Marquette Asset Management LLC8,919$89K0.0%N/A0.107% 5/18/2021 Opaleye Management Inc.376,900$4.41M0.6%+34.0%4.516% 5/17/2021 Deerfield Management Company L.P. Series C373,117$4.37M0.1%-60.1%4.471% 5/14/2021 Dimensional Fund Advisors LP41,459$485K0.0%-4.8%0.497% 5/13/2021 Renaissance Technologies LLC332,419$3.89M0.0%+7.6%3.983% 5/12/2021 Northern Trust Corp2,960$35K0.0%-75.5%0.035% 5/11/2021 Acadian Asset Management LLC5,879$69K0.0%+65.0%0.070% SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.5/7/2021 BlackRock Inc.71,078$831K0.0%+2.9%0.853% 4/14/2021Investors Financial Group LLC29,200$342K0.2%+60.4%0.350% 2/22/2021 West Financial Advisors LLC784$28K0.0%N/A0.009% 2/18/2021 Verition Fund Management LLC9,835$351K0.0%N/A0.119% 2/16/2021One68 Global Capital LLC5,855$209K0.4%N/A0.071% 2/16/2021 ExodusPoint Capital Management LP37,203$1.33M0.0%N/A0.448% 2/12/2021 Opaleye Management Inc.281,287$10.05M1.3%+16.8%3.390% 2/11/2021 Northern Trust Corp12,081$432K0.0%+292.0%0.146% 2/10/2021 Renaissance Technologies LLC308,812$11.03M0.0%+0.9%3.722% 2/9/2021 Wells Fargo & Company MN117,660$4.20M0.0%+1.1%1.418% 2/9/2021 Bank of New York Mellon Corp17,493$625K0.0%N/A0.211% 1/21/2021 Foster Group Inc.7,283$221K0.0%N/A0.088% 1/19/2021Investors Financial Group LLC18,200$650K0.4%-16.4%0.219% 11/12/2020 Connor Clark & Lunn Investment Management Ltd.31,978$442K0.0%-12.5%0.386% 11/10/2020 Texas Yale Capital Corp.16,000$221K0.0%+6.7%0.193% 11/9/2020 Acadian Asset Management LLC5,161$71K0.0%-85.7%0.062% 11/5/2020 Wells Fargo & Company MN116,392$1.61M0.0%+3.7%1.403% 10/14/2020Investors Financial Group LLC21,766$301K0.2%-81.1%0.262% 9/15/2020 Two Sigma Advisers LP13,298$219K0.0%-5.0%0.160% 8/14/2020 Logos Global Management LP50,000$825K0.2%N/A0.606% 8/14/2020Jefferies Group LLC120,651$1.99M0.0%+13.0%1.462% (Data available from 1/1/2016 forward) LUMO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LUMO shares? During the previous two years, 9 institutional investors and hedge funds held shares of Lumos Pharma. The most heavily invested institutionals were Acuitas Investments LLC ($413K), Greenwich Wealth Management LLC ($252K), Blackstone Inc. ($222K), Opaleye Management Inc. ($166K), Marquette Asset Management LLC ($85K), Key Financial Inc ($84K), and K2 Principal Fund L.P. ($57K).Learn more on LUMO's institutional investors. What percentage of Lumos Pharma stock is owned by institutional investors? 33.99% of Lumos Pharma stock is owned by institutional investors. Learn more on LUMO's institutional investor holdings. Which institutional investors have been buying Lumos Pharma stock? The following institutional investors have purchased Lumos Pharma stock in the last 24 months: Greenwich Wealth Management LLC ($76.34K), Opaleye Management Inc. ($21.52K), Marquette Asset Management LLC ($17.77K), Key Financial Inc ($10.92K), Private Advisor Group LLC ($9K), and Urban Wealth Management LLC ($3.49K). How much institutional buying is happening at Lumos Pharma? Institutional investors have bought a total of 139,040 shares in the last 24 months. This purchase volume represents approximately $620.63K in transactions. Which Lumos Pharma major shareholders have been selling company stock? The following institutional investors have sold Lumos Pharma stock in the last 24 months: Blackstone Inc. ($389.52K), K2 Principal Fund L.P. ($40.03K), Acuitas Investments LLC ($28.63K), Private Advisor Group LLC ($20K), and Marquette Asset Management LLC ($5.33K). How much institutional selling is happening at Lumos Pharma? Institutional investors have sold a total of 483,504 shares in the last 24 months. This volume of shares sold represents approximately $1.53M in transactions. Related Companies: Aclaris Therapeutics Institutional Ownership Annovis Bio Institutional Ownership vTv Therapeutics Institutional Ownership Aileron Therapeutics Institutional Ownership Journey Medical Institutional Ownership Landos Biopharma Institutional Ownership Tempest Therapeutics Institutional Ownership BioXcel Therapeutics Institutional Ownership Lantern Pharma Institutional Ownership Viveon Health Acquisition Institutional Ownership This page (NASDAQ:LUMO) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.